DUBLIN, Dec. 3, 2024 (Globe Newswire) — The “Artificial Intelligence (AI) in Cancer Markets” report has been added to ResearchAndMarkets.com’s offering.
Artificial intelligence (AI) in cancer market was valued at USD 2.2 billion in 2024 and is projected to reach USD 6.3 billion by 2029, at a CAGR of 23.1%. Drivers of market growth include the increasing incidence of cancer and the expanding application of AI in cancer drug discovery and development. Data collection and processing challenges, false positives, and AI bias are expected to pose challenges to market growth.
This report segments the global market for AI in Cancer by cancer type, application, end user, and region.
Based on cancer types, breast cancer segment will account for the largest share among cancer types in 2023. It is expected to grow at a CAGR of 21.8% during the forecast period. By application, the diagnostic segment is projected to grow at a CAGR of 23.7% during the forecast period. This segment accounted for 35.7% of the application market in 2023 and is expected to reach $2.3 billion by the end of 2029. By end user, hospitals accounted for 55.8% of the end user market in 2023. This segment is expected to grow at a CAGR of 23.4% during the forecast period and reach a value of $3.6 billion by the end of 2029. In the region, North America accounted for the largest market share of 44.8% among all regions in 2023. This large share can be attributed to the increasing number of AI startups and the increasing incidence of cancers such as breast and prostate cancer.
Report scope
This report highlights the market potential of AI technologies in current and future cancer applications. It provides an in-depth analysis of market drivers, restraints, and opportunities. The report also covers the market forecast till 2029 and also presents the competitive landscape and product analysis.
This report provides market estimates and forecasts based on applications, cancer types, and regions. By application type, the market is segmented into cancer screening, diagnosis, treatment, drug discovery and development, and others. Based on cancer type, the market is segmented into breast cancer, lung cancer, prostate cancer, gastrointestinal cancer, brain cancer, etc. By end user, the market is segmented into hospitals, diagnostic centers, pharmaceutical companies, and research institutes. The report includes profiles of key companies and detailed information about their business segments, financials, product portfolio, and recent developments.
The report includes:
42 Data Tables and 44 Additional Tables Latest Overview of the Global Market for Artificial Intelligence (AI) in Cancer Analysis of Global Market Trends with 2021-2023 Data, Forecast to 2024, and Compound Annual Growth Rate Forecast AI in Cancer with market share analysis by type, application, end user, and type (CAGR) to 2029 Assessment of market size and revenue growth prospects Assessment of market dynamics, including regional drivers, constraints, and opportunities Coverage of current and emerging applications of AI in cancer, as well as information on theranostics and generative AI tools ESG challenges and Discussion of industry practices Assessment of vendor landscape, including market share of major players Information on recent mergers, acquisitions, expansions, alliances, investments, divestitures, product launches, and other strategic developments Leading companies Company Profile of Siemens Healthineers, GE Players within the industry such as Healthcare, NVIDIA, Lunit, etc.
Key attributes:
Report attribute details No. Number of pages 111 Forecast period 2024 – 2029 Estimated market value in 2024 (USD) 2.2 billion USD Predicted market value by 2029 (USD) 6.3 billion USD Average annual growth rate 23.1% Target region Worldwide
Main topics covered:
Chapter 1 Overview
Chapter 2 Market Overview
Current and emerging applications of AI in cancer diagnosis, treatment, screening and early detection, drug discovery and development
Chapter 3 Market Trends
AI in Drug Discovery and Development Driving the Market Rising Cancer Incidence Market Constraints Data Collection and Privacy False Positives and Bias Market Opportunities AI-Enabled Hardware Products
Chapter 4 Emerging Technologies
AITheranostics and AI-generated AI tools for early detection of multiple cancersFederated Learning
Chapter 5 Market Segmentation Analysis
Market Analysis by Cancer Type Breast Cancer Lung Cancer Prostate Cancer Gastrointestinal Cancer Brain Cancer Other Cancer Market Analysis by Application Diagnosis Diagnostics Drug Discovery and Development Treatment Cancer Screening Other Market Analysis by Application End User Market Size and Forecast Hospital Diagnosis Center Pharmaceutical Company Research Institute Geographical Breakdown Market Analysis by Region
Chapter 6 Competitive Intelligence
Partnership M&A activity investment and financing patent analysis
Chapter 7 Sustainability of AI in the Cancer Market
AI Sustainability in the Cancer Industry Understanding ESG Data Environmental Performance Social Performance Governance Performance Conclusion
Company Profile
Azra AIConcertaiGE HealthcareICADLunitMedian TechnologiesNvidia Corp.Quest DiagnosticsSiemens Healthineers
For more information on this report, please visit https://www.researchandmarkets.com/r/qq1zgu.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
Artificial Intelligence (AI) in the Cancer Market
